A strategy to decrease the use of risky drugs in the elderly
Susan M. Fosnight, RPh, CGP, BCPS
Clinical Staff Pharmacist, Department of Pharmacy, Summa Health System, Akron, OH
Kyle R. Allen, DO
Chief, Division of Geriatric Medicine, Medical Director, Post Acute and Senior Services, Summa Health System; Associate Professor of Clinical Internal and Family Medicine, Northeastern Ohio Universities College of Medicine, Akron, OH
Carolyn M. Holder, MSN, RN, CNS
Geriatrics Coordinator, Post Acute and Senior Services, Summa Health System, Akron, OH
Susan Hazelett, MSN, RN
Research Associate, Summa Health System, Akron, OH
Address: Susan M. Fosnight, RPh, CGP, BCPS, Department of Pharmacy, Summa Health System, 525 East Market Street, Akron, OH 44304; e-mail firstname.lastname@example.org
This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTMany medications that are safe in most patients pose serious risks in older patients, including functional decline, delirium, falls, and poorer outcomes. We describe our institution's program of "academic detailing," designed to reduce the use of three high-risk drugs in elderly patients.